Safety Shot Announces Pricing of $10.6 Million Registered Direct Offering
Safety Shot (NASDAQ:SHOT) has announced the pricing of a $10.6 million registered direct offering with an institutional investor.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Safety Shot (NASDAQ:SHOT) has announced the pricing of a $10.6 million registered direct offering with an institutional investor. The offering includes 28,648,648 shares of common stock priced at $0.37 per share.
Additionally, the company issued warrants in a concurrent private placement to purchase up to 57,297,296 shares at an exercise price of $0.37 per share, exercisable immediately with a five-year expiration. The offering, expected to close around July 22, 2025, follows shareholder approval of Safety Shot's merger with Yerbaé and aims to strengthen the company's balance sheet for expanded operations.
Positive
- Secured $10.6 million in gross proceeds to strengthen balance sheet
- Strategic timing following shareholder approval of Yerbaé merger
- 5-year warrant coverage provides potential additional capital through exercises
- Institutional investor participation demonstrates market confidence
Negative
- Significant dilution to existing shareholders through 28.6M new shares
- Additional potential dilution from 57.3M warrant shares
- Offering price of $0.37 may represent a discount to market price
Insights
Safety Shot secured $10.6M funding through share offering at $0.37, strengthening finances for Yerbaé merger integration.
Safety Shot has secured
This financing appears strategically timed to support the company's recently approved merger with Yerbaé. The
From a balance sheet perspective, this
The involvement of an institutional investor rather than retail funding sources suggests a higher level of due diligence and potential confidence in the company's business model and merger strategy. The fact that Dominari Securities served as the exclusive placement agent indicates professional financial intermediation for this transaction, adding another layer of validation.
Notably, this offering was conducted under an existing shelf registration (Form S-3), demonstrating the company had proactively established the regulatory framework for rapid capital raising when needed. The expected July 22 closing date shows an efficient execution timeline for accessing these funds.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SCOTTSDALE, AZ, July 21, 2025 (GLOBE NEWSWIRE) -- Safety Shot, Inc. (Nasdaq: SHOT) (“Safety Shot” or the “Company”), a wellness and dietary supplement company, today announced the pricing of a registered direct offering with an institutional investor for the purchase and sale of 28,648,648 shares of its common stock at a purchase price of
In a concurrent private placement, the Company also issued warrants to purchase up to 57,297,296 shares of common stock. The warrants have an exercise price of
The gross proceeds to the Company from the offering are expected to be approximately
The closing of the registered direct offering and concurrent private placement is expected to occur on or about July 22, 2025.
The shares of common stock offered in the registered direct offering are being offered pursuant to a shelf registration statement on Form S-3 (File No. 333-282315) that was filed with the U.S. Securities and Exchange Commission (the “SEC”) on and declared effective by the SEC on November 1, 2024. A prospectus supplement relating to and describing the terms of the registered direct offering will be filed with the SEC and will be available on the SEC's website at www.sec.gov.
“This financing is a critical step that comes at a pivotal time for our company, following the recent shareholder approval of our merger with Yerbaé,” said Jarrett Boon, CEO of Safety Shot. “It significantly strengthens our balance sheet and provides us with the capital to support the daily business activities of our expanded operations, execute a seamless integration, and accelerate our commercial footprint. We appreciate the confidence shown by our new institutional partner and are now better positioned than ever to drive long-term value for our shareholders.”
Dominari Securities, LLC. acted as the exclusive placement agent for the offering.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
About Safety Shot, Inc. Safety Shot, Inc., a wellness and dietary supplement company, has developed Sure Shot, the first patented wellness product on Earth that lowers blood alcohol content by supporting its metabolism, while boosting clarity, energy, and overall mood. Sure Shot is available for purchase online at www.sureshot.com, www.walmart.com and Amazon.
Investor Relations: Phone: 561-244-7100 Email: investors@drinksafetyshot.com
Forward-Looking Statements: This press release contains forward-looking statements, including statements about the Company’s ability to regain compliance with the Nasdaq minimum bid price requirement. These forward-looking statements are based on the current expectations of the management of Safety Shot and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Safety Shot, Inc. undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.